Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.82
+0.01 (0.17%)
Apr 8, 2026, 3:46 PM HKT
-24.90%
Market Cap 628.56M
Revenue (ttm) 4.88B
Net Income (ttm) 51.49M
Shares Out 108.00M
EPS (ttm) 0.48
PE Ratio 12.21
Forward PE n/a
Dividend 0.34 (5.91%)
Ex-Dividend Date May 27, 2026
Volume 500
Average Volume 25
Open 5.82
Previous Close 5.81
Day's Range 5.82 - 5.82
52-Week Range 4.30 - 7.75
Beta -0.90
RSI 36.95
Earnings Date Mar 27, 2026

About Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. It also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and chang... [Read more]

Sector Healthcare
Founded 1984
Employees 849
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2289
Full Company Profile

Financial Performance

In 2025, Charmacy Pharmaceutical's revenue was 4.38 billion, a decrease of -1.15% compared to the previous year's 4.44 billion. Earnings were 46.27 million, a decrease of -13.16%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.